[The relationship of gastrin, pepsinogen, and Helicobacter pylori in erosive reflux esophagitis]
- PMID: 18451689
[The relationship of gastrin, pepsinogen, and Helicobacter pylori in erosive reflux esophagitis]
Abstract
Background/aims: Helicobacter pylori (H. pylori) infection is known as a major cause of atrophic gastritis and is associated with serum gastrin, pepsinogen, and gastric acid secretion. There is still a controversial association between gastroesophageal reflux disease and H. pylori infection. This study was designed to investigate the relationship among serum gastrin, pepsinogen, and H. pylori infection in the erosive reflux esophagitis (ERD) patients.
Methods: Patients who were diagnosed as ERD by one gastroenterologist at the Kangnam St. Mary's hospital were prospectively enrolled. The persons without ERD in the control group were matched for age and sex. We examined the gastrin, pepsinogen I (PG I), PG II, PG I/II ratio, and H. pylori infection.
Results: Forty five patients were enrolled in ERD group and 66 persons in control group. The H. pylori infection rate in ERD group was lower than that in the control group (11.1% vs. 43.9%, p<0.001). PG I/II ratio in ERD group was higher than that in the control group (7.0+/-3.1 vs. 5.3+/-2.6, p=0.003). The PG II (p=0.016) and gastrin (p=0.029) in ERD group were lower than those in the control group. BMI in ERD group was higher than that in the control group (24.5 vs. 23.1 kg/m2, p=0.013).
Conclusions: The H. pylori infection rate in ERD group was lower and PG I/II ratio was higher than that in the control group. Reflux esophagitis is thought to be reversely associated with the atrophy of gastric mucosa.
Similar articles
-
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.Aliment Pharmacol Ther. 2008 Aug 15;28(4):491-6. doi: 10.1111/j.1365-2036.2008.03769.x. Epub 2008 Jun 16. Aliment Pharmacol Ther. 2008. PMID: 18557987
-
Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:25-32. doi: 10.1111/j.1365-2036.2004.01970.x. Aliment Pharmacol Ther. 2004. PMID: 15298602
-
[Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].Korean J Gastroenterol. 2007 Aug;50(2):84-91. Korean J Gastroenterol. 2007. PMID: 17928751 Korean.
-
[Helicobacter pylori and the development of atrophic gastritis].Nihon Rinsho. 1993 Dec;51(12):3231-5. Nihon Rinsho. 1993. PMID: 8283639 Review. Japanese.
-
Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle.Am J Gastroenterol. 1998 Mar;93(3):394-400. doi: 10.1111/j.1572-0241.1998.00394.x. Am J Gastroenterol. 1998. PMID: 9517647 Review.
Cited by
-
Inverse correlation between gastroesophageal reflux disease and atrophic gastritis assessed by endoscopy and serology.World J Gastroenterol. 2022 Feb 28;28(8):853-867. doi: 10.3748/wjg.v28.i8.853. World J Gastroenterol. 2022. PMID: 35317098 Free PMC article.
-
Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry.Indian J Gastroenterol. 2011 Feb;30(1):12-21. doi: 10.1007/s12664-010-0078-0. Epub 2011 Jan 26. Indian J Gastroenterol. 2011. PMID: 21267690
-
The effect of Helicobacter pylori on gastroesophageal reflux disease.JSLS. 2012 Apr-Jun;16(2):260-3. doi: 10.4293/108680812x13427982376860. JSLS. 2012. PMID: 23477175 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical